UroGen Pharma Ltd (URGN) — Cash Flow Quality Index

Latest as of December 2016: 1.03x

UroGen Pharma Ltd (URGN) has a Cash Flow Quality Index of 1.03x as of December 2016. Operating cash flow of $13.35 Million exceeds net income of $12.92 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow to debt ratio of UroGen Pharma Ltd to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1.03x

Operating CF / Net Income

Operating Cash Flow

$13.35 Million

USD

Net Income

$12.92 Million

USD

Data as of

Dec 2016

Most recent filing

Annual Cash Flow Quality Index for UroGen Pharma Ltd (None–None)

Year-by-year earnings quality comparison for UroGen Pharma Ltd.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.